Dangdai International Group Co. Ltd 13D and 13G filings for CELLULAR BIOMEDICINE GROUP, IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-19 7:50 pm Sale | 2021-02-19 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 0 0.000% | -2,270,000 (Position Closed) | Filing |
| 2020-08-12 11:16 am Unchanged | 2020-08-11 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.700% | 0 (Unchanged) | Filing |
| 2020-06-24 7:31 pm Unchanged | 2020-06-24 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing |
| 2020-03-31 10:16 am Unchanged | 2020-03-30 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing |
| 2020-02-24 1:50 pm Unchanged | 2020-02-21 | 13D | CELLULAR BIOMEDICINE GROUP, IN CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.800% | 0 (Unchanged) | Filing |